Celebrating 25 years Est 1999-2024
*Across 3 years $2158.56 only $755.50
Aventis Named to List of Top 100 Companies for Working Mothers Receives Honors Three Years Running BRIDGEWATER, N.J., Sept. 21...
The sanofi-aventis Group Thanks Its Team Members and Shareholders and Launches Its New Visual Identity PARIS, Sept. 16 /PRNewswire-FirstCall/...
Aventis to Move Forward With Reissuance Process for Contested Lovenox Patent BRIDGEWATER, N.J., July 27 /PRNewswire-FirstCall/ -- Aventis...
New Data Confirm Lovenox(R) is an Effective Antithrombotic for Treatment of Acute Coronary Syndromes SYNERGY, A to Z and a Systematic Overview of...
Sanofi-Synthelabo's Offer for Aventis Expiration Date of Offers PARIS, June 23 /PRNewswire-FirstCall/ -- On June 22, 2004, the Autorite...
Sanofi-Synthelabo's Offer for Aventis; Adjustment of Offer Terms on Approval of Aventis Dividend PARIS, June 14 /PRNewswire-FirstCall/...
Sanofi-Synthelabo's Offer for Aventis Expiration Date of Offers PARIS, June 1 /PRNewswire-FirstCall/ -- On June 1, 2004, the Autorite des marches...
Aventis and U.S. NIH Enter Into Pandemic Influenza Vaccine Agreement World's Largest Vaccine Developer to Produce Investigational Vaccine...
Sanofi-Synthelabo's Offer for Aventis U.S. Offer Extended to Wednesday, June 30, 2004 PARIS, May 26 /PRNewswire-FirstCall/ -- Sanofi-Synthelabo...
Surveillance Study Finds Newly-Approved Antibiotic KETEK(R) (telithromycin) Tablets 99% Effective In Vitro Against Streptococcus...
Aventis Receives Priority Review Designation for the Registrational Application to Support the Use of Taxotere(R) in Women with Early-Stage Breast...
Sanofi-Synthelabo's Offer for Aventis Request for Additional Information from the Federal Trade Commission PARIS, May 5 /PRNewswire-FirstCall/...
Aventis Pasteur Statement on New Influenza Immunization Recommendations for Infants, Young Children and Their Close Contacts SWIFTWATER, Pa...
Aventis Reports First-Quarter Results for 2004 All Figures Refer to 2004 Group vs 2003 Core Unless Otherwise Stated STRASBOURG, France, April 29...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.